1. Home
  2. JYNT vs GNFT Comparison

JYNT vs GNFT Comparison

Compare JYNT & GNFT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • JYNT
  • GNFT
  • Stock Information
  • Founded
  • JYNT 2010
  • GNFT 1999
  • Country
  • JYNT United States
  • GNFT France
  • Employees
  • JYNT N/A
  • GNFT N/A
  • Industry
  • JYNT Multi-Sector Companies
  • GNFT Biotechnology: Biological Products (No Diagnostic Substances)
  • Sector
  • JYNT Miscellaneous
  • GNFT Health Care
  • Exchange
  • JYNT Nasdaq
  • GNFT Nasdaq
  • Market Cap
  • JYNT 170.1M
  • GNFT 186.3M
  • IPO Year
  • JYNT 2014
  • GNFT 2019
  • Fundamental
  • Price
  • JYNT $11.19
  • GNFT $3.92
  • Analyst Decision
  • JYNT Strong Buy
  • GNFT Strong Buy
  • Analyst Count
  • JYNT 2
  • GNFT 1
  • Target Price
  • JYNT $15.50
  • GNFT $13.00
  • AVG Volume (30 Days)
  • JYNT 42.7K
  • GNFT 2.9K
  • Earning Date
  • JYNT 08-07-2025
  • GNFT 09-18-2025
  • Dividend Yield
  • JYNT N/A
  • GNFT N/A
  • EPS Growth
  • JYNT N/A
  • GNFT N/A
  • EPS
  • JYNT N/A
  • GNFT 0.03
  • Revenue
  • JYNT $52,789,479.00
  • GNFT $73,187,701.00
  • Revenue This Year
  • JYNT $9.48
  • GNFT $5.15
  • Revenue Next Year
  • JYNT $11.15
  • GNFT N/A
  • P/E Ratio
  • JYNT N/A
  • GNFT $126.97
  • Revenue Growth
  • JYNT 71.05
  • GNFT 105.01
  • 52 Week Low
  • JYNT $9.58
  • GNFT $2.55
  • 52 Week High
  • JYNT $13.47
  • GNFT $6.42
  • Technical
  • Relative Strength Index (RSI)
  • JYNT 46.48
  • GNFT 50.10
  • Support Level
  • JYNT $10.72
  • GNFT $3.67
  • Resistance Level
  • JYNT $11.75
  • GNFT $4.19
  • Average True Range (ATR)
  • JYNT 0.37
  • GNFT 0.10
  • MACD
  • JYNT -0.05
  • GNFT -0.00
  • Stochastic Oscillator
  • JYNT 44.34
  • GNFT 46.62

About JYNT The Joint Corp.

The Joint Corp develops, owns, operates, supports, and manages chiropractic clinics through direct ownership, management arrangements, franchising, and the sales of regional developer rights throughout the United States. The doctors of chiropractic develop personalized treatment plans to relieve patients' pain and deliver ongoing preventative care. The Company has two operating business segments; the Corporate Clinics segment is comprised of the operating activities of the company-owned or managed clinics, and The Franchise Operations segment is comprised of the operating activities of the franchise business unit. The company generates maximum revenue from the Corporate clinic's segment.

About GNFT GENFIT S.A.

Genfit SA is a biotechnology company focused on metabolic and inflammatory diseases, with a particular focus on the liver and gastroenterology. The company's research and development activity relies on its expertise in modulating gene expression through nuclear receptors. Genfit utilizes acquisitions, strategic alliances, and licensing agreements in order to fund the further development of its products. It has one segment the research and development of medicines and diagnostic solutions, the marketing of which depends on the success of the clinical development phase.

Share on Social Networks: